Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19
J Clin Exp Hepatol
.
2021 Mar-Apr;11(2):273-275.
doi: 10.1016/j.jceh.2020.10.001.
Epub 2020 Oct 10.
Authors
Pramod Kumar
1
,
Anand Kulkarni
1
,
Mithun Sharma
1
,
Padaki N Rao
1
Affiliation
1
Department of Hepatology and Liver Transplantation, Asian Institute of Gastroenterology Hospitals, Survey No 136, Mindspace Rd, Gachibowli, Hyderabad, Telangana 500032 India.
PMID:
33071519
PMCID:
PMC7546995
DOI:
10.1016/j.jceh.2020.10.001
No abstract available
Keywords:
Daclatasvir; Hepatitis C; SARS-CoV-2; Sofosbuvir.